Parallax Volatility Advisers, L.P. Coherus Bio Sciences, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $52,326 - $101,223	7,298 New	7,298 $70,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $150,222 - $226,159	-16,508 Reduced 65.97%	8,514 $94,000
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $200,408 - $345,614	24,001 Added 2350.73%	25,022 $220,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $11,333 - $14,804	1,021	1,021 $14,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.